Abstract:Objective: Enhanced de novo lipogenesis (DNL) in hepatocytes is a major contributor to nonalcoholic fatty liver disease (NAFLD). Fatty acid translocase (FAT/CD36) is involved in the pathogenesis of NAFLD through facilitating free fatty acids uptake. Here, we explored the effects of CD36 on DNL and elucidated the underlying mechanisms. Methods: We generated hepatocyte-specific CD36 knockout (CD36LKO) mice to study in vivo effects of CD36 on DNL under high-fat diet (HFD). Lipid deposition and DNL were analyzed in primary hepatocytes isolated from CD36LKO mice or HepG2 cells with CD36 overexpression. RNA sequence, co-immunoprecipitation, and proximity ligation assay were carried out to determine its role in regulating DNL. Results: Hepatic CD36 expression was upregulated in NAFLD mice and patients, and CD36LKO mice exhibited attenuated HFD-induced hepatic steatosis and insulin resistance. We identified hepatocyte CD36 as a key regulator for DNL in the liver. Sterol regulatory element-binding protein 1 (SREBP1) and its downstream lipogenic enzymes such as FASN, ACCa, and ACLY were significantly downregulated in the liver of HFD-fed CD36LKO mice, whereas overexpression CD36 stimulated insulin-mediated DNL and lipid droplet formation in vitro. Mechanistically, CD36 was activated by insulin and formed a complex with insulin-induced gene-2 (INSIG2) that disrupts the interaction between SREBP cleavage activating protein (SCAP) and INSIG2, thereby leading to the translocation of SREBP1 from ER to Golgi for processing. Furthermore, treatment with 25-hydroxycholesterol or betulin molecules shown to enhance SCAP-INSIG interaction, reversed the effects of CD36 on SREBP1 cleavage. Conclusions: Our findings identify a previously unsuspected role of CD36 in the regulation of hepatic lipogenic program through mediating SREBP1 processing by INSIG2, providing additional evidence for targeting CD36 in NAFLD. Crown Copyright (c) 2021 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes

Opposite Regulation Of Cd36 Ubiquitination By Fatty Acids And Insulin - Effects On Fatty Acid Uptake

Loss of CD36 Impairs Hepatic Insulin Signaling by Enhancing the Interaction of PTP1B with IR.

CD36 as a target to prevent cardiac lipotoxicity and insulin resistance

Facilitation of Fatty Acid Uptake by CD36 in Insulin-Producing Cells Reduces Fatty-Acid-induced Insulin Secretion and Glucose Regulation of Fatty Acid Oxidation.

Lipid Oversupply Induces CD36 Sarcolemmal Translocation Via Dual Modulation of PKCζ and TBC1D1: an Early Event Prior to Insulin Resistance

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Regulation of AMPK Activation by CD36 Links Fatty Acid Uptake to β-Oxidation

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells

CD36 Plays a Negative Role in the Regulation of Lipophagy in Hepatocytes Through an AMPK-dependent Pathway

Insulin-stimulated translocation of the fatty acid transporter CD36 to the plasma membrane is mediated by the small GTPase Rac1 in adipocytes

CD36 Promotes De Novo Lipogenesis in Hepatocytes Through INSIG2-dependent SREBP1 Processing

Cd36 Level And Trafficking Are Determinants Of Lipolysis In Adipocytes

Microvascular insulin resistance associates with enhanced muscle glucose disposal in CD36 deficiency

Enhanced ECCD36 Signaling Promotes Skeletal Muscle Insulin Resistance in Female Mice

Insulin and AMPK Regulate FA Translocase/cd36 Plasma Membrane Recruitment in Cardiomyocytes Via Rab GAP AS160 and Rab8a Rab GTPase

CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function

Insulin Restores UCP3 Activity and Decreases Energy Surfeit to Alleviate Lipotoxicity in Skeletal Muscle.

CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis

Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function

WDFY2 Potentiates Hepatic Insulin Sensitivity and Controls Endosomal Localization of the Insulin Receptor and IRS1/2